Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness

被引:201
|
作者
Liao, Tsai-Tsen [1 ]
Yang, Muh-Hwa [1 ,2 ,3 ]
机构
[1] Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Genome Res Ctr, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan
关键词
epithelial-mesenchymal transition; metastasis; plasticity; stemness; CIRCULATING TUMOR-CELLS; SMAD-INTERACTING PROTEIN-1; TRANSCRIPTION FACTOR SNAIL; GROWTH-FACTOR RECEPTOR; E-CADHERIN REPRESSION; REGULATES E-CADHERIN; EMT-ACTIVATOR ZEB1; GENE-EXPRESSION; MIR-200; FAMILY; PROSPECTIVE IDENTIFICATION;
D O I
10.1002/1878-0261.12096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-mesenchymal transition (EMT) is an important process in embryonic development, fibrosis, and cancer metastasis. During cancer progression, the activation of EMT permits cancer cells to acquire migratory, invasive, and stem-like properties. A growing body of evidence supports the critical link between EMT and cancer stemness. However, contradictory results have indicated that the inhibition of EMT also promotes cancer stemness, and that mesenchymal-epithelial transition, the reverse process of EMT, is associated with the tumor-initiating ability required for metastatic colonization. The concept of 'intermediate-state EMT' provides a possible explanation for this conflicting evidence. In addition, recent studies have indicated that the appearance of 'hybrid' epithelial-mesenchymal cells is favorable for the establishment of metastasis. In summary, dynamic changes or plasticity between the epithelial and the mesenchymal states rather than a fixed phenotype is more likely to occur in tumors in the clinical setting. Further studies aimed at validating and consolidating the concept of intermediate-state EMT and hybrid tumors are needed for the establishment of a comprehensive profile of cancer metastasis.
引用
收藏
页码:792 / 804
页数:13
相关论文
共 50 条
  • [1] Epithelial-mesenchymal plasticity in breast cancer metastasis
    Kang, Yibin
    CANCER RESEARCH, 2013, 73
  • [2] Epithelial-mesenchymal Plasticity in Breast Cancer Metastasis
    T. Blick
    C. A. Pinto
    D. Huang
    A. Tachtsidis
    E. Widodo
    H. Hugo
    R. Wafai
    D. Gunasinghe
    I. Haviv
    M. E. Lenburg
    R. M. Neve
    D.F. Newgreen
    M.L. Ackland
    M. Waltham
    E. W. Thompson
    中国肺癌杂志, 2009, 12 (06) : 1 - 2
  • [3] EPITHELIAL-MESENCHYMAL TRANSITION AND STEMNESS PLASTICITY ARE EARLY EVENTS IN HEPATOCARCINOGENESIS
    Santo, Joana Espirito
    Ladeirinha, Ana
    Alarcao, Ana
    Neves, Lia
    Strelet, Eugeniu
    Reis, Marco
    Santos, Rui
    Carvalho, Lina
    HEPATOLOGY, 2021, 74 : 688A - 689A
  • [4] Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
    Lu, Wei
    Kang, Yibin
    DEVELOPMENTAL CELL, 2019, 49 (03) : 361 - 374
  • [5] MET: roles in epithelial-mesenchymal transition and cancer stemness
    Jeon, Hye-Min
    Lee, Jeongwu
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (01)
  • [6] Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated
    Keywan Mortezaee
    Jamal Majidpoor
    Ebrahim Kharazinejad
    Medical Oncology, 39
  • [7] Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection
    Wu, Kou-Juey
    Yang, Muh-hwa
    BIOSCIENCE REPORTS, 2011, 31 (06) : 449 - 455
  • [8] Controversies around epithelial-mesenchymal plasticity in cancer metastasis
    Williams, Elizabeth D.
    Gao, Dingcheng
    Redfern, Ndrew
    Thompson, Erik W.
    NATURE REVIEWS CANCER, 2019, 19 (12) : 716 - 732
  • [9] Epithelial-mesenchymal plasticity in carcinoma metastasis
    Tsai, Jeff H.
    Yang, Jing
    GENES & DEVELOPMENT, 2013, 27 (20) : 2192 - 2206
  • [10] Revisiting mTOR and Epithelial-Mesenchymal Transition
    Herrerias, Mariana M.
    Budinger, G. R. Scott
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2020, 62 (06) : 669 - 670